ARCHIVES

Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards

This article is from The Cancer Letter archive.

Vol. 35 No. 30 | July 31, 2009

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups, NCI To Talk About Overlaps

March 14, 1975

ACS Says New Tax Policy Hurts Charity Funds

April 25, 1980

Royston Retires At Kimmel; Cancer Care Gives Awards.

June 22, 2001

Approval Granted For New Formulation of Lupron Depot

July 29, 2011

NCI Calls Fisher “A Dominant Force” In Breast Cancer

September 5, 1997

Breast Cancer A Heterogeneous Disease, Concepts Changing: Fisher

June 13, 1980